JPRN-UMIN000040181
Completed
未知
An integrated multi-omics study of tumor heterogeneity in patients with treatment-resistant malignant cancer - A study of tumor heterogeneity in patients with treatment-resistant malignant cancer
Conditionsmalignant cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- malignant cancer
- Sponsor
- Kansai Electric Power Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Other than those above
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1/2
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.2024-512152-38-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela100
Recruiting
Not Applicable
Characterization of genetic intratumoral heterogeneity of benign and malignant soft tissue tumors for prediction of genetic aberrations by machine learning.D48.1Connective and other soft tissueDRKS00024705MU München1,000
Recruiting
Not Applicable
ongitudinal exploratory analysis of tumor-specific T-cell immunity and microbiome/calprotectin testing in patients with solid tumorsmalignancysolid tumor10027476NL-OMON55886eids Universitair Medisch Centrum400
Recruiting
Not Applicable
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
Unknown
Not Applicable
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastasesSCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor celNL-OMON29203niversity Medical Centre Groningen30